Literature DB >> 27567465

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

Paulus Kirchhof, Stefano Benussi, Dipak Kotecha, Anders Ahlsson, Dan Atar, Barbara Casadei, Manuel Castella, Hans-Christoph Diener, Hein Heidbuchel, Jeroen Hendriks, Gerhard Hindricks, Antonis S Manolis, Jonas Oldgren, Bogdan Alexandru Popescu, Ulrich Schotten, Bart Van Putte, Panagiotis Vardas, Stefan Agewall1, John Camm1, Gonzalo Baron Esquivias1, Werner Budts1, Scipione Carerj1, Filip Casselman1, Antonio Coca1, Raffaele De Caterina1, Spiridon Deftereos1, Dobromir Dobrev1, José M Ferro1, Gerasimos Filippatos1, Donna Fitzsimons1, Bulent Gorenek1, Maxine Guenoun1, Stefan H Hohnloser1, Philippe Kolh1, Gregory Y H Lip1, Athanasios Manolis1, John McMurray1, Piotr Ponikowski1, Raphael Rosenhek1, Frank Ruschitzka1, Irina Savelieva1, Sanjay Sharma1, Piotr Suwalski1, Juan Luis Tamargo1, Clare J Taylor1, Isabelle C Van Gelder1, Adriaan A Voors1, Stephan Windecker1, Jose Luis Zamorano1, Katja Zeppenfeld1.   

Abstract

Entities:  

Keywords:  AF surgery; Antiarrhythmic drugs; Anticoagulation; Atrial fibrillation; Cardioversion; Catheter ablation; Guidelines; Left atrial ablation; Left atrial appendage occlusion; Non-vitamin K antagonist oral anticoagulants; Pulmonary vein isolation; Rate control; Rhythm control; Upstream therapy; Valve repair; Vitamin K antagonists

Mesh:

Year:  2016        PMID: 27567465     DOI: 10.1093/europace/euw295

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


× No keyword cloud information.
  437 in total

1.  Clinical background including anticoagulant therapy in patients with atrial fibrillation in a community-based survey: the Saitama AF Registry.

Authors:  Yasushi Wakabayashi; Yoshitaka Sugawara; Kanna Fujita; Takekuni Hayashi; Nahoko Ikeda; Tomio Umemoto; Hiroshi Wada; Kenichi Sakakura; Hiroshi Funayama; Takeshi Mitsuhashi; Hideo Fujita; Shin-Ichi Momomura
Journal:  Heart Vessels       Date:  2017-06-20       Impact factor: 2.037

Review 2.  Role of the anticoagulant monitoring service in 2018: beyond warfarin.

Authors:  Nathan P Clark
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

3.  A novel protocol for initial heparin administration during catheter ablation for atrial fibrillation in patients taking direct oral anticoagulants.

Authors:  Hideyuki Kishima; Takanao Mine; Eiji Fukuhara; Kenki Ashida; Masaharu Ishihara; Tohru Masuyama
Journal:  Heart Vessels       Date:  2018-11-02       Impact factor: 2.037

4.  Myeloperoxidase in atrial fibrillation: association with progression, origin and influence of renin-angiotensin system antagonists.

Authors:  Erik Holzwirth; Jelena Kornej; Sandra Erbs; Danilo Obradovic; Andreas Bollmann; Gerhard Hindricks; Holger Thiele; Petra Büttner
Journal:  Clin Res Cardiol       Date:  2019-06-24       Impact factor: 5.460

5.  Hyperuricemia is associated with an increased prevalence of paroxysmal atrial fibrillation in patients with type 2 diabetes referred for clinically indicated 24-h Holter monitoring.

Authors:  A Mantovani; R Rigolon; A Civettini; B Bolzan; G Morani; S Bonapace; C Dugo; G Zoppini; E Bonora; G Targher
Journal:  J Endocrinol Invest       Date:  2017-07-15       Impact factor: 4.256

6.  Is Catheter Ablation Better Than Antiarrhythmic Drugs for the Treatment of Atrial Fibrillation?

Authors:  Balaji Natarajan; Srishti Nayak; Ramdas G Pai
Journal:  Int J Angiol       Date:  2020-03-05

7.  Left atrial thrombus despite continuous direct oral anticoagulant or warfarin therapy in patients with atrial fibrillation: insights into rates and timing of thrombus resolution.

Authors:  Michael S Wu; James Gabriels; Mohammad Khan; Nada Shaban; Salvatore A D'Amato; Christopher F Liu; Steven M Markowitz; James E Ip; George Thomas; Parmanand Singh; Bruce B Lerman; Apoor Patel; Jim W Cheung
Journal:  J Interv Card Electrophysiol       Date:  2018-08-04       Impact factor: 1.900

8.  Severity of Hypertension Correlates with Risk of Thromboembolic Stroke.

Authors:  Hui Pang; Bing Han; Qiang Fu; Qiumei Cao
Journal:  J Cardiovasc Transl Res       Date:  2017-05-31       Impact factor: 4.132

Review 9.  Dabigatran etexilate: appropriate use in patients with chronic kidney disease and in the elderly patients.

Authors:  Mauro Molteni; Mario Bo; Giovanni Di Minno; Giuseppe Di Pasquale; Simonetta Genovesi; Danilo Toni; Paolo Verdecchia
Journal:  Intern Emerg Med       Date:  2017-04-24       Impact factor: 3.397

10.  Clinical analysis of antithrombotic treatment and occurrence of stroke in elderly patients with nonvalvular persistent atrial fibrillation.

Authors:  Lu-Jiao Yu; Shuai Chen; Yao Xu; Zi-Xin Zhang
Journal:  Clin Cardiol       Date:  2018-10-16       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.